Press releases
FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
NIOX GROUP PLC (“NIOX” or the “Company” and, together with its subsidiaries, the “Group”) FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 Oxford, UK – 1 April 2025: NIOX Group plc (AIM: NIOX), a medical device company focused on…
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Oxford, UK – 24 September 2024: NIOX Group plc (AIM: NIOX), a company engaged in the design, development, and commercialisation of medical devices for asthma diagnosis and management, today announces its unaudited interim results for the six months ended 30…
FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Oxford, UK – 26 March 2024: NIOX Group plc (AIM: NIOX), a medical device company focused on point of care asthma diagnosis and management, today announces its results for the year ended 31 December 2023 (“FY23”). Financial highlights Revenue growth…
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Oxford, UK – 26 September 2023: NIOX Group plc (AIM: NIOX), a company engaged in the design, development, and commercialisation of medical devices for asthma diagnosis and management, today announces its unaudited interim results for the six months ended 30…
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (“UK MAR”), and is disclosed…
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
NIOX GROUP PLC (formerly Circassia Group plc) (“NIOX” or the “Company” and, together with its subsidiaries, the Group“) Oxford, UK – 14 September 2022: NIOX Group plc (LSE: NIOX), a company engaged in the design, development, and commercialisation of medical devices for asthma…
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
Oxford, UK – 22 March 2022: Circassia Group plc (“Circassia” or “the Group”; AIM: CIR), a medical device company focused on point of care asthma diagnosis and management, today announces its audited results for the year ended 31 December 2021.…
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
Oxford, UK – 16 September 2021: Circassia Group plc (LSE: CIR), a medical device company focused on point of care asthma diagnosis and management, today announces its unaudited interim results for the six months ended 30 June 2021 (“H1 2021”).…
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
Oxford, UK – 24 March 2021: Circassia Group plc (“Circassia” or the “Company” and, together with its subsidiaries, the “Group”) (LSE: CIR) today announces its audited results for the year ended 31 December 2020 and a post-period update. Financial highlights…
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020
Oxford, UK – 17 September 2020: Circassia Group plc (“Circassia” or “the Company”) (LSE: CIR), a leading medical device business focused on respiratory disease, today announces its unaudited interim results for the six months ended 30 June 2020. Financial highlights…